PARLIAMENTARY WRITTEN QUESTION
Medicines and Healthcare products Regulatory Agency: Redundancy (15 October 2021)

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of redundancies at the Medicines and Healthcare Products Regulatory Agency on its day-to-day functions.

Asked by:
Feryal Clark (Labour)

The Department regularly meets with officials at the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss a range of issues, including its transformation plans.

The Department has not made a specific assessment of the potential effect of redundancies at the MHRA. The MHRA continues to involve trades unions and employees through formal consultation as well as continuing opportunities for engagement with senior leaders.

Answered by:
Edward Argar (Conservative)
21 October 2021